To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
DepoDur, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of SkyePharma PLC. It was approved by the FDA in 2004 for use as a post-surgical pain reliever. In Europe it was approved by the Medicines and Healthcare products Regulatory Agency in 2006.
Additional recommended knowledge
It is a one-time injection (during or shortly after surgery) that maintains a therapeutically effective level of morphine in the patient's bloodstream for 48 hours.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DepoDur". A list of authors is available in Wikipedia.|